Can Mounjaro Cause Neck and Shoulder Pain?

Neck and shoulder pain are not named in Mounjaro's UK Summary of Product Characteristics as a recognised side effect, but musculoskeletal discomfort has been reported by some people on treatment.
Rapid weight loss (including the kind tirzepatide produces in clinical trials) can temporarily alter posture and place different demands on neck and shoulder muscles.
Low protein intake during calorie restriction is a well-documented driver of muscle loss; preserving muscle with adequate protein and resistance activity matters on any GLP-1 treatment.
Any new pain that is severe, persistent, or accompanied by other symptoms (such as chest tightness, radiating arm pain, or numbness) needs prompt medical assessment, not watchful waiting.

Neck and shoulder pain are not listed as common side effects of Mounjaro in the UK prescribing information, but people do report musculoskeletal aches during treatment — and there are plausible reasons why. Mounjaro (tirzepatide) slows gastric emptying and reduces appetite significantly, which can affect posture, activity levels, and muscle mass if protein intake drops too low. If you have developed neck or shoulder discomfort since starting tirzepatide, this page explains what the clinical evidence says, what is likely causing it, and when to speak to a prescriber. These are prescription-only medicines; a GPhC-registered prescriber should always be your first call for any new or worsening symptom.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What may be driving neck and shoulder discomfort on Mounjaro — and what to do

Step 1: Check what Mounjaro's product information actually says

The starting point for any concern like this is the official prescribing record. Mounjaro's UK Summary of Product Characteristics (published on the electronic Medicines Compendium) does not list neck pain or shoulder pain under common, uncommon, or rare adverse effects. The recognised side-effect profile is dominated by gastrointestinal effects: nausea, vomiting, diarrhoea, constipation, reflux, and fatigue, particularly in the weeks after starting or increasing the dose. That matters because it means a prescriber reporting to the MHRA's Yellow Card scheme would currently classify musculoskeletal complaints as unlisted, which is exactly why reporting them is useful. If you are experiencing shoulder or neck symptoms you think are linked to tirzepatide, submitting a Yellow Card report helps build the evidence base for everyone who follows.

A question our prescribers hear most weeks is whether a new ache is "caused by the injection", and the honest answer is: sometimes the connection is indirect rather than direct. The medicine itself is unlikely to be irritating your neck. The changes it produces in your body, however, are a different matter.

Step 2: Understand the indirect pathways that connect GLP-1 treatment to muscle discomfort

Tirzepatide works as a dual GIP and GLP-1 receptor agonist, reducing appetite substantially. That appetite reduction is the point, but it also means many people eat less protein than their muscles need, particularly during the earlier, more nauseous weeks of treatment. Muscle that is under-nourished adapts by reducing in volume, and the smaller, weaker stabilising muscles of the neck and shoulder girdle are among the first affected. You can read more about how tirzepatide works on our medicine overview page.

Rapid fat loss also shifts your centre of gravity and can subtly change how you hold yourself, placing new strain on the cervical and thoracic spine. People who were previously carrying significant weight often held a posture adapted to that distribution; as weight falls quickly, those compensatory patterns can produce aches in unfamiliar places. For a broader look at whether Mounjaro can cause back pain, that page covers the same indirect mechanisms in more detail.

Finally, GLP-1 treatment tends to reduce overall energy levels during the adjustment phase, which can mean people move less. Deconditioning (even mild) reduces the support muscles provide to joints, and the neck and shoulders are among the most posture-dependent joints in the body.

Step 3: Know when the discomfort needs prompt medical attention

Most musculoskeletal aches that arise during weight loss are benign and improve with time, gentle movement, and better protein intake. Some patterns, though, need assessment without delay. Pain that radiates from the neck or shoulder down an arm, is accompanied by tingling or numbness, or is severe and sudden could reflect nerve compression, a musculoskeletal injury, or (in the chest-and-left-shoulder combination) a cardiac symptom. None of these are specifically caused by tirzepatide, but they are not something to wait out.

The NHS tirzepatide information page lists the symptoms that should prompt you to seek urgent care: severe abdominal pain radiating to the back (a pancreatitis signal), allergic reactions, and significant dehydration from vomiting. Neck and shoulder pain is not in that category, but if you have any doubt about a new symptom, contact your prescriber or NHS 111 rather than looking for reassurance online. You can also find specific information on sore neck and shoulders on Mounjaro and on neck pain during tirzepatide treatment in our related pages.

Step 4: Practical steps while you wait to speak to your prescriber

While you arrange a conversation with your clinical team, there are sensible things you can do. Prioritise protein at every meal, a common target during GLP-1 treatment is 1.2 to 1.6 grams per kilogram of body weight daily, though your prescriber may tailor this. Keep moving: light resistance work and gentle neck and shoulder mobility exercises preserve muscle better than rest alone. Staying well hydrated supports muscle function too, and dehydration compounds the fatigue some people feel in the early weeks.

If cost or access has you wondering about the wider context of private treatment, our Mounjaro overview covers the full picture of how the medicine is used in the UK, and our weight-loss treatments page is the place to start a free consultation if you have not yet spoken to one of our prescribers. For context on how Mounjaro pricing has changed in the UK recently, the Eli Lilly price increase page has the background. Any symptom concern, however, belongs with a prescriber, that is always the right first step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions